Squarepoint Ops LLC Mirum Pharmaceuticals, Inc. Transaction History

Squarepoint Ops LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$23.57 - $34.85 $616,449 - $911,466	26,154 Added 63.38%	67,421 $2.31 Million
Q1 2024 May 15, 2024	SELL	$24.92 - $30.02 $2.27 Million - $2.73 Million	-90,945 Reduced 68.79%	41,267 $1.04 Million
Q4 2023 Feb 14, 2024	BUY	$27.14 - $34.93 $2.58 Million - $3.32 Million	94,953 Added 254.85%	132,212 $3.9 Million
Q2 2023 Aug 14, 2023	BUY	$23.51 - $30.09 $875,959 - $1.12 Million	37,259 New	37,259 $963,000
Q4 2022 Feb 14, 2023	BUY	$17.59 - $23.83 $265,908 - $360,238	15,117 New	15,117 $294,000
Q1 2021 May 17, 2021	SELL	$16.29 - $21.92 $349,273 - $469,986	-21,441 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$15.75 - $25.45 $34,965 - $56,499	-2,220 Reduced 9.38%	21,441 $374,000
Q3 2020 Nov 16, 2020	SELL	$18.4 - $26.59 $79,598 - $115,028	-4,326 Reduced 15.46%	23,661 $456,000
Q2 2020 Aug 14, 2020	SELL	$11.51 - $20.97 $79,177 - $144,252	-6,879 Reduced 19.73%	27,987 $545,000
Q1 2020 May 15, 2020	BUY	$9.38 - $23.79 $327,043 - $829,462	34,866 New	34,866 $488,000

195

54.1M

177K

167K

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.79B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.